Paradigms of sulfotransferase catalysis the mechanism of sult2a1

Journal of Biological Chemistry

Volumn 289, Issue 38, 2014, Pages 26474-26480

  Wang, Ting ^b   Cook, Ian ^b   Falany, Charles N ^a   Leyh, Thomas S ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE 3' PHOSPHATE 5' PHOSPHOSULFATE; SULFOTRANSFERASE; SULFOTRANSFERASE 2A1; UNCLASSIFIED DRUG; ALCOHOL SULFOTRANSFERASE; PRASTERONE; PROTEIN BINDING;

ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME BINDING; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME REGULATION; ENZYME RELEASE; ENZYME STRUCTURE; HUMAN; NONHUMAN; PROTEIN EXPRESSION; STEADY STATE; SULFONATION; ANTAGONISTS AND INHIBITORS; BIOCATALYSIS; CHEMICAL MODEL; CHEMISTRY; KINETICS;

BIOCATALYSIS; DEHYDROEPIANDROSTERONE; HUMANS; KINETICS; MODELS, CHEMICAL; PHOSPHOADENOSINE PHOSPHOSULFATE; PROTEIN BINDING; SULFOTRANSFERASES;

EID: 84907200601     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.573501     Document Type: Article

References (50)

1. 1680of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor. J. Biol. Chem. 266, 740-746
2. Kotov, A., Falany, J. L., Wang, J., and Falany, C. N. (1999) Regulation of estrogen activity by sulfation in human Ishikawa endometrial adenocarci-noma cells. J. Steroid Biochem. Mol. Biol. 68, 137-144
3. Tuddenham, E. G., Cooper, D. N., Gitschier, J., Higuchi, M., Hoyer, L. W., Yoshioka, A., Peake, I. R., Schwaab, R., Olek, K., Kazazian, H. H., et al. (1991) Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene. Nucleic Acids Res. 19, 4821-4833
4. Parker, C. R. (1999) Dehydroepiandrosterone and dehydroepiandros-terone sulfate production in the human adrenal during development and aging. Steroids 64, 640-647
5. Visser, T. J. (1994) Role of sulfation in thyroid hormone metabolism. Chem. Biol. Interact. 92, 293-303
6. Tangemann, K., Bistrup, A., Hemmerich, S., and Rosen, S. D. (1999) Sul-fation of a high endothelial venule-expressed ligand for L-selectin: effects on tethering and rolling of lymphocytes. J. Exp. Med. 190, 935-942
7. Goldstein, D. S., Swoboda, K. J., Miles, J. M., Coppack, S. W., Aneman, A., Holmes, C., Lamensdorf, I., and Eisenhofer, G. (1999) Sources and physiological significance of plasma dopamine sulfate. J. Clin Endocrinol. Metab. 84, 2523-2531
8. Lipscombe, R. J., Nakhoul, A. M., Sanderson, C. J., and Coombe, D. R. (1998) Interleukin-5 binds to heparin/heparan sulfate: a model for an interaction with extracellular matrix. J. Leukoc. Biol. 63, 342-350
9. Poeppel, P., Habetha, M., Marcão, A., Büssow, H., Berna, L., and Giesel-mann, V. (2005) Missense mutations as a cause of metachromatic leu-kodystrophy: degradation of arylsulfataseA inthe endoplasmic reticulum. Febs. J. 272, 1179-1188
10. Cook, I. T., Duniec-Dmuchowski, Z., Kocarek, T. A., Runge-Morris, M., and Falany, C. N. (2009) 24-Hydroxycholesterol sulfation by human cyto-solic sulfotransferases: formation of monosulfates and disulfates, molecular modeling, sulfatase sensitivity and inhibition of LXR activation. Drug Metab. Dispos. 37, 2069-2078
11. Kuiper, G.G., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., and Gustafsson, J. A. (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138, 863-870
12. Argiolas, A., and Hedlund, H. (2001) The pharmacology and clinical pharmacokinetics of apomorphine SL. BJUInt. 88, Suppl. 3, 18-21
13. Robertson, J. F., and Harrison, M. (2004) Fulvestrant: pharmacokinetics and pharmacology. Br. J. Cancer 90, Suppl. 1, S7-S10
14. Nagar, S., Walther, S., and Blanchard, R. L. (2006) Sulfotransferase (SULT) 1A1 polymorphic variants ∗1, ∗2, and ∗3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation. Mol. Pharmacol. 69, 2084-2092
15. Bai, Q., Xu, L., Kakiyama, G., Runge-Morris, M.A., Hylemon, P. B., Yin, L., Pandak, W. M., and Ren, S. (2011) Sulfation of 25-hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells. Atherosclerosis 214, 350-356
16. Zhang, H., Varlamova, O., Vargas, F. M., Falany, C. N., and Leyh, T. S. (1998) Sulfuryl transfer: the catalytic mechanism of human estrogen sulfotransferase. J. Biol. Chem. 273, 10888-10892
17. Matsubayashi, Y., and Sakagami, Y. (2006) Peptide hormones in plants. Annu. Rev. Plant. Biol. 57, 649-674
18. Stowers, L., and Logan, D. W. (2010) Sexual dimorphism in olfactory signaling. Curr. Opin. Neurobiol. 20, 770-775
19. Selvan, R. S., Ihrcke, N. S., and Platt, J. L. (1996) Heparan sulfate in immune responses. Ann. N.Y. Acad. Sci. 797, 127-139
20. Anderson, J. A., Fredenburgh, J. C., Stafford, A. R., Guo, Y. S., Hirsh, J., Ghazarossian, V., and Weitz, J. I. (2001) Hypersulfated low molecular weight heparin with reduced affinity for antithrombin acts as an anticoagulant by inhibiting intrinsic tenase and prothrombinase. J. Biol. Chem. 276, 9755-9761
21. Mesiano, S., and Jaffe, R. B. (1997) Developmental and functional biology of the primate fetal adrenal cortex. Endocr. Rev. 18, 378-403
22. Steventon, G. B., Heafield, M. T., Waring, R. H, and Williams, A. C. (1989) Xenobiotic metabolism in Parkinson's disease. Neurology 39, 883-887
23. Li, L., and Falany, C. N. (2007) Elevated hepatic SULT1E1 activity in mouse models of cystic fibrosis alters the regulation of estrogen responsive proteins. J. Cyst. Fibros. 6, 23-30
24. Moore, K. L. (2003) The biology and enzymology of protein tyrosine O-sulfation. J. Biol. Chem. 278, 24243-24246
25. Bischoff, E. D., Daige, C. L., Petrowski, M., Dedman, H., Pattison, J., Ju-liano, J., Li, A. C., and Schulman, I. G. (2010) Non-redundant roles for LXRa and LXR/3 in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice. J. Lipid Res. 51, 900-906
26. Tyapochkin, E., Cook, P. F., and Chen, G. (2008) Isotope exchange at equilibrium indicates a steady state ordered kinetic mechanism for human sulfotransferase. Biochemistry 47, 11894-11899
27. Duffel, M. W., and Jakoby, W. B. (1981) On the mechanism of aryl sulfotransferase. J. Biol. Chem. 256, 11123-11127
28. Whittemore, R. M., Pearce, L. B., and Roth, J. A. (1986) Purification and kinetic characterization of a phenol-sulfating form of phenol sulfotransferase from human brain. Arch. Biochem. Biophys 249, 464-471
29. Whittemore, R. M., Pearce, L. B., and Roth, J. A. (1985) Purification and kinetic characterization of a dopamine-sulfating form of phenol sulfotransferase from human brain. Biochemistry 24, 2477-2482
30. Barnes, S., Waldrop, R., Crenshaw, J., King, R. J., and Taylor, K. B. (1986) Evidence for an ordered reaction mechanism for bile salt: 3'phosphoad-enosine-5'-phosphosulfate:sulfotransferase from rhesus monkey liver that catalyzes the sulfation of the hepatotoxin glycolithocholate. J. Lipid Res. 27, 1111-1123
31. Gulcan, H. O., and Duffel, M. W. (2011) Substrate inhibition in human hydroxysteroid sulfotransferase SULT2A1: studies on the formation of catalytically non-productive enzyme complexes. Arch. Biochem. Biophys 507, 232-240
32. Lu, L. Y., Hsieh, Y. C, Liu, M. Y., Lin, Y. H., Chen, C. J., and Yang, Y. S. (2008) Identification and characterization of two amino acids critical for the substrate inhibition of human dehydroepiandrosterone sulfotrans-ferase (SULT2A1). Mol. Pharmacol 73, 660-668
33. Gamage, N. U., Tsvetanov, S., Duggleby, R. G., McManus, M. E., and Martin, J. L. (2005) The structure of human SULT1A1 crystallized with estradiol: an insight into active site plasticity and substrate inhibition with multi-ring substrates. J. Biol. Chem. 280, 41482-41486
34. Gamage, N. U., Duggleby, R. G., Barnett, A. C., Tresillian, M., Latham, C. F., Liyou, N. E., McManus, M. E., and Martin, J. L. (2003) Structure of a human carcinogen-converting enzyme, SULT1A1: structural and kinetic implications of substrate inhibition. J. Biol. Chem. 278, 7655-7662
35. Cook, I., Wang, T., Falany, C.N., and Leyh, T. S.(2012)Anucleotide-gated molecular pore selects sulfotransferase substrates. Biochemistry 51, 5674-5683
36. Sun, M., and Leyh, T. S. (2010) The human estrogen sulfotransferase: a half-site reactive enzyme. Biochemistry 49, 4779-4785
37. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254
38. Mendes, P. (1997) Biochemistry by numbers: simulation of biochemical pathways with Gepasi 3. Trends Biochem. Sci. 22, 361-363
39. Bevc, S., Konc, J., Stojan, J., Hodoscek, M., Penca, M., Praprotnik, M., and Janezic, D. (2011) ENZO: a web tool for derivation and evaluation of kinetic models of enzyme catalyzed reactions. PLoS One 6, e22265
40. Pauff, S. M., and Miller, S. C. (2013) A trifluoroacetic acid-labile sulfonate protecting group and its use in the synthesis of a near-IR fluorophore. J. Org. Chem. 78, 711-716
41. Falany, C. N., Vazquez, M. E., and Kalb, J. M. (1989) Purification and characterization of human liver dehydroepiandrosterone sulphotrans-ferase. Biochem. J. 260, 641-646
42. Cook, I., Wang, T., Almo, S.C., Kim, J., Falany, C. N., and Leyh, T. S. (2013) The gate that governs sulfotransferase selectivity. Biochemistry 52, 415-424
43. Cleland, W. W. (1975) Partition analysis and the concept of net rate constants as tools in enzyme kinetics. Biochemistry 14, 3220-3224
44. Blanchard, R. L., Freimuth, R. R., Buck, J., Weinshilboum, R. M., and Coughtrie, M. W. (2004) A proposed nomenclature system for the cyto-solic sulfotransferase (SULT) superfamily. Pharmacogenetics 14, 199-211
45. Lu, J. H., Li, H. T., Liu, M. C, Zhang, J. P., Li, M., An, X. M., and Chang, W. R. (2005) Crystal structure of human sulfotransferase SULT1A3 in complex with dopamine and 3'-phosphoadenosine 5'-phosphate. Biochem. Biophys. Res. Commun. 335, 417-423
46. Allali-Hassani, A., Pan, P. W., Dombrovski, L., Najmanovich, R., Tempel, W., Dong, A., Loppnau, P., Martin, F., Thornton, J., Edwards, A. M., Bo-chkarev, A., Plotnikov, A. N., Vedadi, M., and Arrowsmith, C. H. (2007) Structural and chemical profiling of the human cytosolic sulfotrans-ferases. PLoS Biol 5, e97
47. Lee, K. A., Fuda, H., Lee, Y. C, Negishi, M., Strott, C. A., and Pedersen, L. C. (2003) Crystal structure of human cholesterol sulfotransferase (SULT2B1b) in the presence of pregnenolone and 3'-phosphoadenosine 5'-phosphate: rationale for specificity differences between prototypical SULT2A1 andtheSULT2BG1 isoforms. J. Biol. Chem. 278, 44593-44599
48. Shevtsov, S., Petrotchenko, E. V., Pedersen, L. C, and Negishi, M. (2003) Crystallographic analysis of a hydroxylated polychlorinated biphenyl (OH-PCB) bound to the catalytic estrogen binding site of human estrogen sulfotransferase. Environ. Health Perspect. 111, 884-888
49. Saeki, Y., Sakakibara, Y., Araki, Y., Yanagisawa, K., Suiko, M., Nakajima, H., and Liu, M. C (1998) Molecular cloning, expression, and characterization of a novel mouse liver SULT1B1 sulfotransferase. J. Biochem. 124, 55-64
50. Sakakibara, Y., Yanagisawa, K., Katafuchi, J., Ringer, D. P., Takami, Y., Nakayama, T., Suiko, M., and Liu, M. C (1998) Molecular cloning, expression, and characterization of novel human SULT1C sulfotransferases that catalyze the sulfonation of N-hydroxy-2-acetylaminofluorene. J. Biol. Chem. 273, 33929-33935